Tags:Science & Tech
Source:PIB
Subject: Science and Technology, India's international scientific cooperation and biotechnology policy
Key points for Prelims: International Centre for Genetic Engineering and Biotechnology (ICGEB), Department of Biotechnology (DBT), BioE3 policy, Biosafety Level 3 laboratory, Biofoundry for microbial biomanufacturing
Mains syllabus mapping
- General Studies Paper 3: Science and Technology: developments and applications in biotechnology, biofuels, genome editing and their use in health, agriculture and industry; India's international scientific cooperation
- General Studies Paper 2: India's bilateral and multilateral engagement through intergovernmental bodies such as ICGEB
International Centre for Genetic Engineering and Biotechnology: quick facts
- Origin
- Established in 1983 as a project of UNIDO
- Autonomy
- Became an autonomous international organisation on 3 February 1994
- Membership
- Over 65 member states across world regions
Key facts for one-day exams
- ICGEB is an international intergovernmental research organisation.
- ICGEB has components in Trieste, New Delhi and Cape Town.
- The Department of Biotechnology supports ICGEB’s New Delhi component.
- During 2023-2026, 67 researchers from 22 countries undertook or began training at ICGEB New Delhi.
- India’s first biofoundry for microbial biomanufacturing was among the research initiatives highlighted.
India-ICGEB biotechnology cooperation: why in the news?
Dr. Jitendra Singh's visit to ICGEB Trieste on November 16, 2026, highlights India's growing engagement in international biotechnology research and the progress of BioE3-aligned initiatives, including training for 67 researchers from 22 countries.
Union Minister of State (Independent Charge) for Science & Technology and Earth Sciences, Dr. Jitendra Singh, visited the Trieste component of the International Centre for Genetic Engineering and Biotechnology (ICGEB) in Italy on November 16, 2026. During the visit, he reviewed advanced research facilities, met ICGEB Director-General Dr. Lawrence Banks and interacted with Indian researchers and fellows at the Centre, highlighting India's growing role in global biotechnology research and scientific cooperation.
The Minister toured the Biotechnology Development Unit's biopharmaceutical production and training facility, the new Biosafety Level 3 laboratory and the Functional Cell Biology laboratory's high-throughput screening facility. The visit showcased research aligned with India's BioE3 policy, including biobased chemicals and enzymes, climate-resilient agriculture, carbon capture and utilisation, precision biotherapeutics, and marine and space biomanufacturing. Among the initiatives highlighted were India's first biofoundry for microbial biomanufacturing, enzyme and yeast systems for ethanol production, biological carbon capture, genome-edited crops and monoclonal antibodies against infectious diseases.
ICGEB is an intergovernmental research organisation with components in Trieste, New Delhi and Cape Town. The Department of Biotechnology (DBT) supports research, innovation incubation and human resource development at the New Delhi component. Between 2023 and 2026, 67 researchers from 22 countries undertook or began training at ICGEB New Delhi, complemented by workshops on artificial intelligence in biology, drug development, genome editing, carbon capture, microscopy and flow cytometry. The visit underscored the India-ICGEB partnership in advancing biotechnology research and translating it into applications in health, agriculture, industrial processes and environmental sustainability.
Key features and how it works
- Research: over 45 ongoing projects in infectious and non-communicable diseases, and medical, industrial and plant biology biotechnology, across its three components.
- Advanced education through PhD and postdoctoral fellowships, plus international scientific meetings and courses.
- Competitive grants for scientists in member states, and technology transfer to industry.
- At New Delhi, work covers molecular medicine, vaccines, diagnostics, plant biotechnology, bioenergy and genome editing.PIB
- Workshops and scientific exchanges covered AI in biology, drug development, genome editing, carbon capture, microscopy and flow cytometry.PIB
Related Static GK and comparison
- Department of Biotechnology (DBT): established in 1986 under the Ministry of Science and Technology, it administers the development and commercialisation of modern biology and biotechnology in India.
- ICGEB has components in Trieste, Italy; New Delhi, India; and Cape Town, South Africa.icgeb.org
Achievements
- ICGEB has grown to over 65 member states and runs over 45 ongoing research projects across its three components.
- India's first biofoundry for microbial biomanufacturing, inaugurated by Dr. Jitendra Singh, was showcased during the Trieste visit.PIB
- 67 researchers from 22 countries undertook or began training at ICGEB New Delhi between 2023 and 2026.PIB
Challenges
- Keeping three components in different countries aligned on one research agenda is hard, since each sits under a different host setting and funding context.
- Translating lab research on vaccines, biofuels and genome-edited crops into industry products needs sustained industry linkage, which is slow to build.
- Training benefits depend on fellows staying in research after training, so retaining skilled researchers is a continuing concern.
Way forward
- Tracking outcomes of trained fellows and grant projects to show whether training turns into research output.
- Handholding of start-ups and industry partners so that technology transfer moves from lab to market.
- Convergence of ICGEB work with national programmes such as BioE3 so that research priorities in health, agriculture and industry reinforce each other.
Key terms
- Genetic engineering:
- Genetic engineering is the deliberate modification of an organism’s genetic material using biotechnology.
- Biomanufacturing:
- Biomanufacturing uses biological systems, such as cells or microorganisms, to produce materials or products.
- Monoclonal antibodies:
- Monoclonal antibodies are antibodies produced from a single clone of cells that recognise a specific target.
- Technology transfer:
- Technology transfer is the process of sharing or transferring technical knowledge and technologies for use by others.
India-ICGEB biotechnology cooperation: why it matters for exams
Syllabus: Science and Technology: Biotechnology and genetic engineering; International Relations: International scientific cooperation
Common mistake: Examiners may present all 67 researchers as having completed training; they undertook or began training during 2023-2026.
Mains practice questions
Question 1(GS-3 | 250 words | 15 marks)
Examine how India's biotechnology policy framework, as reflected in the BioE3 initiative and its partnership with ICGEB, can contribute to bio-manufacturing, climate-resilient agriculture and sustainable development.
Answer outline
- Introduction: Open by noting that the Minister's visit to ICGEB Trieste in November 2026 showcased how BioE3-aligned research is moving from laboratories into applications in health, farming and industry.
- Body:
- Explain the BioE3 policy's focus areas as seen in the visit: biobased chemicals and enzymes, climate-resilient agriculture, carbon capture and utilisation, and precision biotherapeutics.
- Highlight concrete capacities: India's first biofoundry for microbial biomanufacturing, enzyme and yeast systems for ethanol, genome-edited crops and monoclonal antibodies against infectious diseases.
- Discuss the role of ICGEB as an intergovernmental body with components in Trieste, New Delhi and Cape Town, and DBT's support for research and incubation at New Delhi.
- Assess contributions to sustainability: biological carbon capture and reduced dependence on fossil-based inputs.
- Note constraints such as the need for regulatory clarity on genome-edited crops, biosafety infrastructure and translation of lab research into commercial scale.
- Conclusion: Conclude that BioE3 and ICGEB cooperation can make India a meaningful biotechnology partner if research outputs are backed by regulation, funding and industry linkages.
Question 2(GS-2 | 150 words | 10 marks)
Discuss the significance of international research training programmes, such as the training of 67 researchers from 22 countries at ICGEB New Delhi, in building India's soft power and scientific diplomacy.
Answer outline
- Introduction: Begin by stating that between 2023 and 2026, 67 researchers from 22 countries trained or began training at ICGEB New Delhi, reflecting India's growing role as a host for global science.
- Body:
- Explain how training fellows from many countries builds people-to-people scientific ties and long-term goodwill.
- Note the complementary workshops on artificial intelligence in biology, drug development, genome editing and carbon capture that broaden the skill base.
- Discuss benefits for India in terms of research collaboration, knowledge exchange and enhanced diplomatic standing in the Global South.
- Mention the need to ensure that such programmes translate into lasting institutional partnerships.
- Conclusion: Conclude that scientific training diplomacy strengthens India's soft power when it is sustained, mutually beneficial and linked to shared development goals.
Stuck? Get it in one tap
ICGEB brings countries together for biotechnology research and training. Biotechnology uses biological systems to develop useful products and processes. Its New Delhi component works on areas such as vaccines, crops and bioenergy, with support from the Department of Biotechnology.
- Science and Technology: Biotechnology and genetic engineering
- International Relations: International scientific cooperation
Related concepts: Genetic engineering, Biomanufacturing, Monoclonal antibodies, Technology transfer
Practice questions
Pick an answer, then read the explanation.
- Q1Easy
Which Indian department supports research and development programmes at ICGEB New Delhi?
Explanation: The Department of Biotechnology supports research, innovation incubation and human resource development at ICGEB New Delhi.
- Q2Hard
Consider the following statements about ICGEB:
- 1.It is an international intergovernmental research organisation.
- 2.Its components include Trieste, New Delhi and Cape Town.
- 3.All 67 researchers completed their training at New Delhi during 2023-2026.
Which of the statements given above is/are correct?
Explanation: Statements 1 and 2 are correct: ICGEB is intergovernmental and has the three named components. Statement 3 is incorrect because the researchers undertook or began training; completion by all is not established.
- Q3Medium
How many researchers undertook or began training at ICGEB New Delhi during 2023-2026?
Explanation: A total of 67 researchers from 22 countries undertook or began training during 2023-2026. The other figures do not match that total.
- Q4Medium
What is the purpose of ICGEB’s research and technology-transfer activities?
Explanation: ICGEB promotes research, education, training and technology transfer in biotechnology and life sciences. Its international network combines these functions.
Frequently asked questions
1. What is ICGEB?
The International Centre for Genetic Engineering and Biotechnology is an intergovernmental research organisation working in genetic engineering, biotechnology and life sciences.
2. Where are the components of ICGEB located?
The three components are in Trieste, New Delhi and Cape Town.
3. How many researchers undertook or began training at ICGEB New Delhi during 2023-2026?
A total of 67 researchers from 22 countries undertook or began training during that period.
4. Which Indian department supports ICGEB New Delhi?
The Department of Biotechnology supports its research and development, innovation incubation and human resource development.
All sources
Original16 November 2026 · Read story

